Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Temazepam Treatment Report
What is Temazepam?

Temazepam is a benzodiazepine used for the short-term treatment of insomnia. Off label it is used for the treatment of anxiety; adjunct in the treatment of depression; and management of panic attacks.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Insomnia 6 0
Other 2 1
Treat Parkinson's 1 0
Sleep aid 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 50%
None
1 50%

Most commonly reported side effects

Slow to wake in morning
1 50%
  • Mild
  • Moderate
  • Severe

Dosages

  10mg as needed 15mg as needed 30mg as needed 7.5mg as needed 7.5 mg daily 15 mg daily 45 mg daily
  1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Temazepam (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 50% Did not seem to work: 50%
Doctor's advice
1 50% Doctor's advice: 50%

See all 2 patients who’ve stopped taking Temazepam

Currently Taking Temazepam

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
1
2
1

Stopped Taking Temazepam

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
1
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.